npj Vaccines, 2021 Vaccines against Japanese encephalitis (JE) have been available for decades. Currently, most JE-endemic countries have vaccination programs for their at-risk populations. Even so, JE remains the leading recognized cause of viral encephalitis in Asia.
Kirsten S. Vannice +9 more
doaj +1 more source
The Ecology and Evolution of Japanese Encephalitis Virus
Pathogens, 2021 Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus mainly spread by Culex mosquitoes that currently has a geographic distribution across most of Southeast Asia and the Western Pacific. Infection with JEV can cause Japanese encephalitis (JE),
Peter Mulvey +6 more
doaj +1 more source
A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis [PDF]
, 2017 The structural flexibility or 'breathing' of the envelope (E) protein of flaviviruses allows virions to sample an ensemble of conformations at equilibrium.
Diamond, Michael S +4 more
core +5 more sources
Flavivirus reverse genetic systems, construction techniques and applications: A historical perspective [PDF]
, 2015 The study of flaviviruses, which cause some of the most important emerging tropical and sub-tropical human arbovirus diseases, has greatly benefited from the use of reverse genetic systems since its first development for yellow fever virus in 1989 ...
Aubry, Fabien +3 more
core +1 more source
Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011. [PDF]
PLoS Neglected Tropical Diseases, 2014 Japanese encephalitis (JE) is arguably one of the most serious viral encephalitis diseases worldwide. China has a long history of high prevalence of Japanese encephalitis, with thousands of cases reported annually and incidence rates often exceeding 15 ...
Xiaoyan Gao +11 more
doaj +1 more source
Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet [PDF]
, 2014 Few data regarding the use of Japanese encephalitis (JE) vaccine in clinical practice are available. We identified 711 travelers at higher risk and 7,578 travelers at lower risk for JE who were seen at US Global TravEpiNet sites from September of 2009 to
Bhushan R. Deshpande +9 more
core +1 more source
Global research priorities for infections that affect the nervous system [PDF]
, 2015 Infections that cause significant nervous system morbidity globally include viral (for example, HIV, rabies, Japanese encephalitis virus, herpes simplex virus, varicella zoster virus, cytomegalovirus, dengue virus and chikungunya virus), bacterial (for ...
Bangirana, Paul +5 more
core +1 more source
Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents
Advanced Functional Materials, EarlyView.Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras +6 more
wiley +1 more source
Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
Vaccines, 2020 Flaviviruses include several medically important viruses, such as Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV).
Naru Zhang +3 more
doaj +1 more source
Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020. [PDF]
, 2017 OBJECTIVE: To estimate the economic impact likely to be achieved by efforts to vaccinate against 10 vaccine-preventable diseases between 2001 and 2020 in 73 low- and middle-income countries largely supported by Gavi, the Vaccine Alliance.
Clark, Andrew +20 more
core +4 more sources